Correlation Between Iovance Biotherapeutics and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Spyre Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Spyre Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Spyre Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iovance and Spyre is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Spyre Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.98 times more return on investment than Spyre Therapeutics. However, Iovance Biotherapeutics is 1.02 times less risky than Spyre Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.37 per unit of risk. If you would invest 900.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would lose (104.00) from holding Iovance Biotherapeutics or give up 11.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Spyre Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Spyre Therapeutics |
Iovance Biotherapeutics and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Spyre Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Spyre Therapeutics vs. Puma Biotechnology | Spyre Therapeutics vs. Iovance Biotherapeutics | Spyre Therapeutics vs. Day One Biopharmaceuticals | Spyre Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |